Furthermore, positive pAKT staining was detected in the patient’s biopsy and PDX models by immunohistochemistry, indicating the AKT pathway was activated, however at lower levels than a PTEN-negative prostate cancer specimen that was used as positive control (Figure S1). This evidence concerns the gene PTEN and prostate cancer.